title: [Perception of adverse reactions of chemotherapy and hormone therapy by women treated for breast cancer].
abstract: BACKGROUND
  In Europe, breast cancer is the most common cancer among women. His treatment (TTT) can have a significant impact on daily life.
  
  
  OBJECTIVE
  Explore the experienced short-term side effects (SE) of chemotherapy and hormonal therapy by women themselves, the information delivered and the place of the general practitioner (GP).
  
  
  METHODS
  Qualitative study by individual interview, conducted from January to May 2015, with 14 women followed for no metastatic breast cancer after chemotherapy and possible initiation of hormone therapy, at the Cancer Institute of the Loire (France).
  
  
  RESULTS
  The SE of chemotherapy, except vomiting, have appeared very trying (fatigue, pains oral and cutaneous involvement), punctuated and accentuated by the cures. They were resounding on daily life, requiring family or professional assistance. Falling dander, considered stigmatizing, violated the person and femininity. The women have estimated to be well informed. They had appreciated the initial response of the pivot nurse. The least expected SE of hormone therapy, hot flashes and articular pains might limit activities. To counteract these side effects, mostly accepted to prevent recidivism, a remedy for complementary therapies was frequent. The GP was solicited for some SE, sometimes for complementary medicine (CM).
  
  
  CONCLUSIONS
  Over the cures, women suggested support meetings, a more sustainable action of the pivot nurse, a better attention to their complaints and a more personalized information. The development of TTT less EI provider was desired. The effect of CM on SE should be explored.
authors.affiliation: Pôle innovation-santé, service universitaire de médecine générale, faculté de médecine Jacques-Lisfranc, université Jean-Monnet, campus Santé Innovations, 10, rue de la Marandière, 42270 Saint-Priest-en-Jarez, France.
authors.forename: Maud
authors.initials: M
authors.lastname: Jodar
authors.affiliation: Département d'oncologie médicale, institut de cancérologie Lucien-Neuwirth, 42271 Saint-Priest-en-Jarez, France.
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Jacquin
authors.affiliation: Pôle innovation-santé, service universitaire de médecine générale, faculté de médecine Jacques-Lisfranc, université Jean-Monnet, campus Santé Innovations, 10, rue de la Marandière, 42270 Saint-Priest-en-Jarez, France. Electronic address: josette.vallee@univ-st-etienne.fr.
authors.forename: Josette
authors.initials: J
authors.lastname: Vallée
mesh_terms: D000328:Adult; D000368:Aged; D000505:Alopecia / Q000139:chemically induced / Q000523:psychology; D000970:Antineoplastic Agents / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000523:psychology; D000529:Complementary Therapies / Q000706:statistics & numerical data; D003875:Drug Eruptions / Q000209:etiology / Q000523:psychology; D005221:Fatigue / Q000139:chemically induced / Q000523:psychology; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D009059:Mouth Diseases / Q000139:chemically induced; D010146:Pain / Q000139:chemically induced; D010353:Patient Education as Topic; D036301:Qualitative Research; D011788:Quality of Life
chemical_list: D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal
keywords: Adverse drug reaction; Antineoplastic agents; Breast cancer; Cancer du sein; Effets indésirables; General practitioner; Médecin généraliste; Médicaments antinéoplasiques